ReviewFrontiers in immunology2021
To React or Not to React: The Dilemma of Fish Immune Systems Facing Myxozoan Infections.
Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Tissue-Specific Transcriptomic Insights into Myxozoan Infections: Immune and Stress Responses in the Kidney and Head Cartilage of Rainbow Trout.International journal of molecular sciences · 2026Article
- Stressor interactions affect myxozoan abundance in a 42-year dataset from the Pearl River, Louisiana, USA.Parasitology · 2026Article
- Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions.Neurochemical research · 2026Review
- Review of Major and Minor Pathogens of Adult Pacific Salmon (Pathogens (Basel, Switzerland) · 2026Review
- Molecular characterization of twoParasitology · 2025Article
- Sustained production and purification ofParasitology · 2025Article
- Renal myxosporidiosis by an unknown Bivalvulidan myxozoan parasite in Murray River turtles (International journal for parasitology. Parasites and wildlife · 2025Article
- Effects of Genetic Diversity on Health Status and Parasitological Traits in a Wild Fish Population Inhabiting a Coastal Lagoon.Animals : an open access journal from MDPI · 2025Article
- A New Myxobolus (Cnidaria: Myxosporea: Myxobolidae) from the Gill Arch of the Western Creek Chubsucker, Erimyzon claviformis (Cypriniformes: Catostomidae), in Arkansas, USA.Acta parasitologica · 2025Article
- Cecropin anisaxin-2S hasFrontiers in immunology · 2025Article
- Better the devil you know: sympatric fish host copes better than allopatric with a myxozoan parasite.Frontiers in cellular and infection microbiology · 2025Article
- Parental influence on brown trout offspring immune cell composition: An infection study with Tetracapsuloides bryosalmonae.PloS one · 2025Article
- Clinical signs, morphological and phylogenetic characterization of Myxozoan spp. infecting Nile tilapia, Oreochromis niloticus and African catfish, Clarias gariepinus in Qalyubia Governorate, Egypt.BMC veterinary research · 2024Article
- The Tilapia Cyst Tissue Enclosing the ProliferatingInternational journal of molecular sciences · 2024Article
- RNAi-directed knockdown in the cnidarian fish blood parasite Sphaerospora molnari.Scientific reports · 2024Article
- The myxozoansFrontiers in cellular and infection microbiology · 2024Article
- Immunological memory in a teleost fish: common carp IgMFrontiers in immunology · 2024Article
- Red blood cells in proliferative kidney disease-rainbow trout (Frontiers in immunology · 2023Article
- Infectious agents and their physiological correlates in early marine Chinook salmon (Conservation physiology · 2023Article
- Responses to pathogen exposure in sentinel juvenile fall-run Chinook salmon in the Sacramento River, CA.Conservation physiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxozoans are microscopic, metazoan, obligate parasites, belonging to the phylum Cnidaria. In contrast to the free-living lifestyle of most members of this taxon, myxozoans have complex life cycles alternating between vertebrate and invertebrate hosts. Vertebrate hosts are primarily fish, although they are also reported from amphibians, reptiles, trematodes, mollusks, birds and mammals. Invertebrate hosts include annelids and bryozoans. Most myxozoans are not overtly pathogenic to fish hosts, but some are responsible for severe economic losses in fisheries and aquaculture. In both scenarios, the interaction between the parasite and the host immune system is key to explain such different outcomes of this relationship. Innate immune responses contribute to the resistance of certain fish strains and species, and the absence or low levels of some innate and regulatory factors explain the high pathogenicity of some infections. In many cases, immune evasion explains the absence of a host response and allows the parasite to proliferate covertly during the first stages of the infection. In some infections, the lack of an appropriate regulatory response results in an excessive inflammatory response, causing immunopathological consequences that are worse than inflicted by the parasite itself. This review will update the available information about the immune responses against Myxozoa, with special focus on T and B lymphocyte and immunoglobulin responses, how these immune effectors are modulated by different biotic and abiotic factors, and on the mechanisms of immune evasion targeting specific immune effectors. The current and future design of control strategies for myxozoan diseases is based on understanding this myxozoan-fish interaction, and immune-based strategies such as improvement of innate and specific factors through diets and additives, host genetic selection, passive immunization and vaccination, are starting to be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.